Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWPP Regulatory News (WPP)

Share Price Information for WPP (WPP)

Share Price is delayed by 15 minutes
Get Live Data
273.20    1.80 (0.66%)
Bid:
272.70
Ask:
273.00
Spread: 0.30 (0.11%)
Market Cap: £2.95b
WPP Live PriceLast checked at - London Stock Exchange

Intraday WPP Share Chart

Executive Share Awards

15 May 2020 11:01

RNS Number : 0691N
WPP PLC
15 May 2020
 

FOR IMMEDIATE RELEASE 15 May 2020

 

WPP plc ("WPP")

Executive Share Awards

 

Mark Read

WPP's Executive Directors' annual bonuses for 2019 were delivered in the form of a cash award and, for Mark Read, a deferred share award, with the shares comprising 40% of the total bonus achieved. The Executive Share Award (ESA) will vest after a minimum of two years, together with additional shares in respect of accrued dividends. The award is subject to continued employment and malus and clawback provisions. The 2019 ESA award to Mark Read was granted on 14 May 2020 over 97,523 WPP shares.

Details of the Executive Directors' bonuses were published in the WPP 2019 Annual Report and Accounts.

John Rogers

As announced on 1 October 2019, John Rogers has been granted awards under the WPP Share Plans. The awards are to compensate John for the loss of share-based incentives that were forfeited on his departure from Sainsbury's and are of equivalent value and form as the awards forfeited. The awards are all subject to continued employment as well as malus and clawback provisions and restrictive covenants.

Furthermore, the Executive Performance Share Plan (EPSP) awards are subject to a relative Total Shareholder Return (TSR) performance condition, with a Return on Invested Capital (ROIC) underpin. TSR performance will be compared to companies representing the most relevant, listed global competitors, with performance below median resulting in zero vesting. Performance between median and upper decile provides for a vesting opportunity of between 15% and 100%. The awards will vest subject to a ROIC underpin of an average of 7.5% over the performance period. The Compensation Committee has an overriding discretion to determine the extent to which the award will vest.

The EPSP awards were granted to John Rogers on 14 May 2020 as 182,744 and 243,934 nil cost options, which are exercisable over WPP shares or ADRs and also incorporate dividend awards. The extent to which the options will become exercisable in 2021 and 2022 respectively will depend on WPP's performance, as described above, over the period from 1 January 2019 to 31 December 2020 and the period from 1 January 2019 to 31 December 2021.

John has also been granted awards over 66,176 WPP shares, vesting in May 2021 and 52,438 WPP shares, vesting in November 2021. These awards incorporate dividend awards and replicate deferred bonus and deferred share awards John forfeited on his departure from Sainsbury's.

 

At today's date, Mark Read's shareholding in WPP is 296,976 ordinary shares and John Rogers does not currently hold ordinary shares in WPP.

 

 

Contact:

Chris Wade, WPP

+44 (0)20 7282 4600

 

Richard Oldworth, Buchanan Communications

+44 (0)7710 130634

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCEANSSFSPEEEA
Date   Source Headline
18th Jun 20203:47 pmRNSDirector's Dealing
11th Jun 20206:24 pmRNS2020 AGM Board Retirements
11th Jun 20207:00 amRNSWPP appoints Angela Ahrendts DBE to the Board
10th Jun 20202:14 pmRNSResults of AGM
2nd Jun 202012:22 pmRNSShareholder Webcast - 10 June 2020
1st Jun 202012:09 pmRNSVoting Rights and Capital 31 May 2020
29th May 20205:52 pmRNSNotification of Major Holdings
15th May 202011:01 amRNSExecutive Share Awards
12th May 202010:31 amRNSDirector Declaration
11th May 202010:14 amRNSDirector's Dealing
4th May 20203:30 pmRNSBoard Retirement
1st May 202010:20 amRNSDirectors’ Interests
1st May 202010:04 amRNSVoting rights and Capital 30 April 2020
30th Apr 20202:50 pmRNSAnnual Report and Accounts 2019 and AGM 2020
29th Apr 20207:00 amRNSFirst Quarter Trading Update 2020
27th Apr 20205:47 pmRNSDisclosure of Rights Attached to Equity Shares
2nd Apr 20201:45 pmRNSVoting rights and Capital 31 March 2020
31st Mar 20207:00 amRNSUpdate re COVID-19
20th Mar 20207:00 amRNSTransaction in Own Shares
17th Mar 20207:00 amRNSTransaction in Own Shares
16th Mar 20207:00 amRNSTransaction in Own Shares
13th Mar 20204:45 pmRNSDirectors’ Interests
13th Mar 20207:00 amRNSTransaction in Own Shares
12th Mar 20207:00 amRNSTransaction in Own Shares
11th Mar 20207:00 amRNSTransaction in Own Shares
10th Mar 20207:00 amRNSTransaction in Own Shares
9th Mar 20207:00 amRNSTransaction in Own Shares
6th Mar 20207:00 amRNSTransaction in Own Shares
5th Mar 20209:00 amRNSAcquisition
5th Mar 20207:00 amRNSTransaction in Own Shares
4th Mar 20207:00 amRNSDirector's Dealing
4th Mar 20207:00 amRNSTransaction in Own Shares
3rd Mar 20207:00 amRNSTransaction in Own Shares
2nd Mar 202012:19 pmRNSVoting rights and Capital 28 February 2020
28th Feb 20205:14 pmRNSShare repurchase agreement
27th Feb 20207:11 amRNS2019 Preliminary Results
17th Feb 20207:00 amRNSTransaction in Own Shares
14th Feb 20207:00 amRNSTransaction in Own Shares
13th Feb 20207:00 amRNSTransaction in Own Shares
12th Feb 202010:00 amRNSAcquisition
12th Feb 20207:00 amRNSTransaction in Own Shares
11th Feb 20207:00 amRNSTransaction in Own Shares
10th Feb 20207:00 amRNSTransaction in Own Shares
7th Feb 20207:00 amRNSTransaction in Own Shares
6th Feb 20207:00 amRNSTransaction in Own Shares
5th Feb 20207:00 amRNSTransaction in Own Shares
4th Feb 20203:04 pmRNSBoard Appointment
4th Feb 20207:00 amRNSTransaction in Own Shares
3rd Feb 20203:53 pmRNSVoting rights and Capital 31 January 2020
3rd Feb 20207:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.